Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

Completed

Conditions: Melanoma

First Posted Date: 2008-01-08

Last Posted Date: 2023-09-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 754

Registration Number: NCT00588198

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin

Active, not recruiting

Conditions: Skin Cancer

First Posted Date: 2008-01-08

Last Posted Date: 2025-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1889

Registration Number: NCT00588315

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Hauppauge (Consent only), Hauppauge, New York, United States

and more 1 locations

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2008-01-08

Last Posted Date: 2025-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7000

Registration Number: NCT00588029

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: GnRh (Leuprolide)
Drug: Testosterone Gel
Drug: Docetaxel

First Posted Date: 2008-01-07

Last Posted Date: 2023-11-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT00587431

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Peptide Profiles of Women Undergoing Breast Biopsy

Completed

Conditions: Breast Cancer

Interventions: Other: Blood draw

First Posted Date: 2008-01-07

Last Posted Date: 2013-12-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 571

Registration Number: NCT00587821

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Quality of Life in Lung Cancer Survivors

Completed

Conditions: Lung Cancer Survivors

Interventions: Behavioral: questionnaires or telephone interview

First Posted Date: 2008-01-07

Last Posted Date: 2020-01-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 193

Registration Number: NCT00586937

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Studies of Neurological Paraneoplastic Syndromes

Completed

Conditions: Paraneoplastic Neurologic Degenerations (PNDs)

First Posted Date: 2008-01-07

Last Posted Date: 2009-03-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT00587106

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Survey of Sleep Problems in Survivors of Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2008-01-07

Last Posted Date: 2011-09-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 256

Registration Number: NCT00587340

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Phase 2

Completed

Conditions: Hormonal Cycling
Prostate
Cancer

Interventions: Drug: GnRH
Drug: Ketoconazole
Drug: Bicalutamide
Drug: Testosterone transdermal gel
Drug: Estrogen transdermal patch

First Posted Date: 2008-01-07

Last Posted Date: 2016-03-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 36

Registration Number: NCT00586898

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Phase 2

Completed

Conditions: Allogeneic Stem Cell Transplant
Leukemia
Non-Hodgkins
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lymphoblastic Lymphoma
Myelodysplastic Syndrome

Interventions: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant

First Posted Date: 2008-01-07

Last Posted Date: 2017-03-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 129

Registration Number: NCT00587054

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy